FDA Approved: RINVOQ — Original Application (AbbVie Inc.)

View source ↗

Summary

This FDA page documents the original FDA approval of Rinvoq (upadacitinib) from AbbVie under NDA211675, marking the first approval of this JAK inhibitor for rhe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

ORIG AP for RINVOQ (UPADACITINIB)